Table 1 Characteristics of patients
All patients | Patients with decision of care withholding /withdrawal | Patients without decision of care withholding/withdrawal | P | ||||
|---|---|---|---|---|---|---|---|
Patients | N 510 | Median [IQR] | N 403 | Median [IQR] | N 107 | Median [IQR] | |
Age, years | 509 | 70 [61–79] | 402 | 71 [61–79] | 107 | 67 [59–76] | 0.06 |
SAPS 2 | 502 | 65 [50–80] | 398 | 62 [50–76] | 104 | 75 [55–97] | 0.33 |
McCabe score | 506 | 2 [1–3] | 400 | 2 [1–3] | 106 | 2 [1–3] | < 0.01 |
Delay between admission and decision of withdrawal/withholding, days | 375 | 6 [2–12] | 375 | 6 [2–12] | |||
Delay between decision of withdrawal and death, days | 358 | 0 [0–1] | 358 | 0 [0–1] | |||
During the stay in ICU | N (%) | ||||||
|---|---|---|---|---|---|---|---|
Vasoactive drugs | 510 | 390 (76%) | 403 | 287 (71%) | 107 | 103.0 (96%) | < 0.01 |
Invasive ventilation | 510 | 435 (85%) | 403 | 334 (83%) | 107 | 101 (94%) | < 0.01 |
Non-invasive ventilation | 508 | 143 (28%) | 402 | 115 (29%) | 106 | 28 (26%) | 0.75 |
Renal replacement therapy | 510 | 143 (28%) | 403 | 90 (22%) | 107 | 53 (49%) | < 0.01 |
Extra-corporeal life support | 509 | 22 (4%) | 403 | 11 (3%) | 106 | 11 (10%) | < 0.01 |
The day of death | N (%) | ||||||
|---|---|---|---|---|---|---|---|
Vasoactive drugs | 510 | 256 (50%) | 403 | 157 (39%) | 107 | 99 (93%) | < 0.01 |
Invasive ventilation | 509 | 361 (71%) | 402 | 265 (66%) | 107 | 96 (90%) | < 0.01 |
Non-invasive ventilation | 508 | 50 (10%) | 402 | 45 (11%) | 107 | 5 (5%) | 0.07 |
Renal replacement therapy | 501 | 76 (15%) | 394 | 36 (9%) | 107 | 40 (37%) | < 0.01 |
Extra-corporeal life support | 509 | 21 (4%) | 403 | 9 (2%) | 106 | 12 (11%) | < 0.01 |